Henry Schein, US8064071025

Henry Schein expands credit line while analysts rate Henry Schein stock Moderate Buy

Published on 10/05/2026 at 12:23 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Q2 revenue rose 6.7 percent to USD 3.46 billion. Henry Schein stock costs EUR 75.50 on October 5, 2026, plus 0.33 percent versus EUR 75.25.

Isometrische 3D-Illustration der Lieferkette von Medizinprodukten von Produktion zu Klinik
Henry Schein US42548G1040 Wertschöpfungskette vom Hersteller über Lager bis zur Zahnarztpraxis isometrisch dargestellt, Illustration mit AI erstellt.

Henry Schein (ISIN US8064071025) expanded its revolving credit commitments from USD 1.00 billion to USD 1.25 billion on September 21, 2026, according to StockTitan. On September 28, 2026, MarketBeat reported a Moderate Buy consensus from 15 analysts.

Credit capacity reaches USD 1.25 billion

The revised facility runs through September 19, 2031, and can support working capital, capital expenditures, share repurchases, refinancing and potential acquisitions. The filing also identifies Nasdaq Global Select Market as Henry Schein's listing venue and HSIC as its trading symbol.

The financing update gives Henry Schein additional flexibility as it pursues its value creation program. The company is targeting more than USD 200 million in operating income improvements over the next few years, making execution and balance-sheet discipline central to the investment case.

Second-quarter growth supports guidance

In the second quarter of 2026, revenue rose 6.7 percent year over year to USD 3.46 billion, while GAAP net income reached USD 94 million and diluted earnings per share came to USD 0.82, according to The Globe and Mail. Non-GAAP diluted earnings per share increased 15.5 percent from the prior-year period to USD 1.27.

Management raised fiscal 2026 sales-growth guidance to 4.5 percent to 5.5 percent from 3.0 percent to 5.0 percent. Non-GAAP diluted earnings per share guidance moved to USD 5.29-5.39 from USD 5.23-5.37, while second-quarter operating cash flow reached USD 242 million.

Euro quote stays near the middle

Henry Schein was trading at EUR 75.50 at Lang & Schwarz on October 5, 2026 at 12:17 p.m. CEST, up 0.33 percent versus the Lang & Schwarz prior close of EUR 75.25 on October 2, 2026. The primary Nasdaq listing showed a 52-week range of USD 61.95 to USD 92.18 as of October 2, 2026, while market capitalization stood at USD 9.7 billion.

The further course of trading is shown by the continuously updated real-time quote of Henry Schein stock.

Henry Schein stock facts

  • Company: Henry Schein, Inc.
  • ISIN: US8064071025
  • Ticker: HSIC
  • Primary exchange: Nasdaq Global Select Market
  • Price Lang & Schwarz as of October 5, 2026, 12:17 p.m. CEST: EUR 75.50
  • Change versus prior close: plus 0.33 percent
  • Prior close Lang & Schwarz October 2, 2026: EUR 75.25
  • Market capitalization: USD 9.7 billion as of October 2, 2026
  • Sector / Industry: Healthcare / Medical Distribution

More news and analyses on Henry Schein stock

Disclaimer...

en | US8064071025 | HENRY SCHEIN | boerse | 70232209 | bgmi